Literature DB >> 15708912

Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.

Y Naito, I Matsumoto, E Wakamatsu, D Goto, T Sugiyama, R Matsumura, S Ito, A Tsutsumi, T Sumida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15708912      PMCID： PMC1755406          DOI： 10.1136/ard.2004.025478

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

1.  Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome.

Authors:  Y Naito; I Matsumoto; E Wakamatsu; D Goto; S Ito; A Tsutsumi; T Sumida
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

2.  Efficacy prediction of cevimeline in patients with Sjögren's syndrome.

Authors:  Hiroyuki Yamada; Yoichi Nakagawa; Ei Wakamatsu; Takayuki Sumida; Shigeo Yamachika; Yoshiaki Nomura; Kenji Mishima; Ichiro Saito
Journal:  Clin Rheumatol       Date:  2007-01-13       Impact factor: 2.980

3.  RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.

Authors:  M Tahara; H Tsuboi; S Segawa; H Asashima; M Iizuka-Koga; T Hirota; H Takahashi; Y Kondo; M Matsui; I Matsumoto; T Sumida
Journal:  Clin Exp Immunol       Date:  2016-10-11       Impact factor: 4.330

4.  Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome.

Authors:  Fan Xiao; Xiang Lin; Jie Tian; Xiaohui Wang; Qian Chen; Ke Rui; Jie Ma; Shengjun Wang; Qingwen Wang; Xiaoqi Wang; Dongzhou Liu; Lingyun Sun; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

5.  New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Authors:  H Tsuboi; I Matsumoto; E Wakamatsu; Y Nakamura; M Iizuka; T Hayashi; D Goto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

6.  Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome.

Authors:  N Roescher; A Kingman; Y Shirota; J A Chiorini; G G Illei
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

7.  [Psoriasis und Psoriasis arthritis in childhood and adolescence. Overview and consensus statement of the 9th Wörlitz Expert Round Table Discussion 2006 for the Society for Child and Adolescent Rheumatology].

Authors:  M Sticherling; K Minden; R-M Küster; A Krause; M Borte
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

Review 8.  Antibody testing as a diagnostic tool in autonomic disorders.

Authors:  Steven Vernino
Journal:  Clin Auton Res       Date:  2008-08-22       Impact factor: 4.435

9.  A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera.

Authors:  B Preuss; S Tunaru; J Henes; S Offermanns; R Klein
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

10.  Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.

Authors:  Flavia S A Pelegrino; Eugene A Volpe; Niral B Gandhi; De-Quan Li; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Arthritis Res Ther       Date:  2012-11-01       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.